BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 22521751)

  • 21. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.
    Schröder AK; von der Ohe M; Kolling U; Altstaedt J; Uciechowski P; Fleischer D; Dalhoff K; Ju X; Zenke M; Heussen N; Rink L
    Immunology; 2006 Nov; 119(3):317-27. PubMed ID: 17067311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption.
    Janssens AS; Pavel S; Tensen CP; Teunissen MB; Out-Luiting JJ; Willemze R; de Gruijl FR
    Exp Dermatol; 2009 Mar; 18(3):212-7. PubMed ID: 19046297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD.
    Ishii T; Matsuse T; Teramoto S; Matsui H; Miyao M; Hosoi T; Takahashi H; Fukuchi Y; Ouchi Y
    Respir Med; 2000 Sep; 94(9):847-51. PubMed ID: 11001075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
    Dinarello CA
    Int Rev Immunol; 1998; 16(5-6):457-99. PubMed ID: 9646173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.
    Ballak DB; Stienstra R; Tack CJ; Dinarello CA; van Diepen JA
    Cytokine; 2015 Oct; 75(2):280-90. PubMed ID: 26194067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.
    Maedler K; Sergeev P; Ehses JA; Mathe Z; Bosco D; Berney T; Dayer JM; Reinecke M; Halban PA; Donath MY
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8138-43. PubMed ID: 15141093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.
    Zetterström M; Lundkvist J; Malinowsky D; Eriksson G; Bartfai T
    Eur Cytokine Netw; 1998 Jun; 9(2):131-8. PubMed ID: 9681388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation.
    Ruth JH; Bienkowski M; Warmington KS; Lincoln PM; Kunkel SL; Chensue SW
    J Immunol; 1996 Apr; 156(7):2503-9. PubMed ID: 8786311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
    Powell JJ; Fearon KC; Siriwardena AK; Ross JA
    Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [DIRA: life-threatening but treatable inherited inflammatory disease].
    ter Haar NM; van Royen A; van Gijn ME; Frenkel J
    Ned Tijdschr Geneeskd; 2010; 154():A1601. PubMed ID: 20482912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    Carlson NG; Wieggel WA; Chen J; Bacchi A; Rogers SW; Gahring LC
    J Immunol; 1999 Oct; 163(7):3963-8. PubMed ID: 10490998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism.
    Dinarello CA
    Int J Tissue React; 1992; 14(2):65-75. PubMed ID: 1399323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of IL-1beta in type 2 diabetes.
    Dinarello CA; Donath MY; Mandrup-Poulsen T
    Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):314-21. PubMed ID: 20588114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-cells in type 2 diabetes: a loss of function and mass.
    Maedler K; Donath MY
    Horm Res; 2004; 62 Suppl 3():67-73. PubMed ID: 15539803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1, IL-18, and IL-33 families of cytokines.
    Arend WP; Palmer G; Gabay C
    Immunol Rev; 2008 Jun; 223():20-38. PubMed ID: 18613828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 Family Cytokines in Liver Diseases.
    Tsutsui H; Cai X; Hayashi S
    Mediators Inflamm; 2015; 2015():630265. PubMed ID: 26549942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Interleukin-1 Family.
    Yazdi AS; Ghoreschi K
    Adv Exp Med Biol; 2016; 941():21-29. PubMed ID: 27734407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
    Ge Y; Huang M; Yao YM
    Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular interleukin (IL)-1 family cytokine processing enzyme.
    Kwak A; Lee Y; Kim H; Kim S
    Arch Pharm Res; 2016 Nov; 39(11):1556-1564. PubMed ID: 27826753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.